Wedbush Reiterates Outperform on Gossamer Bio, Maintains $4 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Laura Chico has reiterated an Outperform rating on Gossamer Bio (NASDAQ:GOSS) and maintained a $4 price target.
August 13, 2024 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Laura Chico has reiterated an Outperform rating on Gossamer Bio and maintained a $4 price target.
The reiteration of an Outperform rating and the maintenance of a $4 price target by a reputable analyst can positively influence investor sentiment and potentially drive short-term price appreciation for Gossamer Bio.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100